Abstract: Techniques are provided for employing an embedded software defined radio (SDR) in a navigation system. A navigation system implementing the techniques according to an embodiment includes a global positioning system (GPS) receiver configured to acquire and track received GPS signals. The system also includes an SDR configured to process received communication signals. The communication signals include timing data. The SDR is further configured to calculate position and navigation data based on a combination of the processed communication signals and the tracked GPS signals provided by the GPS receiver. The system further includes a system timer configured to provide a common time base for use by the GPS receiver and the SDR. The navigation system is implemented in an application specific integrated circuit (ASIC).

Abstract: Techniques are provided for employing an embedded software defined radio (SDR) in a navigation system. A navigation system implementing the techniques according to an embodiment includes a global positioning system (GPS) receiver configured to acquire and track received GPS signals. The system also includes an SDR configured to process received communication signals. The communication signals include timing data. The SDR is further configured to calculate position and navigation data based on a combination of the processed communication signals and the tracked GPS signals provided by the GPS receiver. The system further includes a system timer configured to provide a common time base for use by the GPS receiver and the SDR. The navigation system is implemented in an application specific integrated circuit (ASIC).

Abstract: Provided herein are compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

Abstract: Provided herein are compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

Abstract: Provided herein are compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

Abstract: Provided herein is the use of compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), alone or in combination with other therapeutic agents, in the treatment of human immunodeficiency virus (HIV).

Abstract: Provided herein are compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

Abstract: Provided herein is the use of compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), alone or in combination with other therapeutic agents, in the treatment of human immunodeficiency virus (HIV).

Abstract: Provided herein are compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

Abstract: Provided herein is the use of compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), alone or in combination with other therapeutic agents, in the treatment of human immunodeficiency virus (HIV). Described herein is the use of IAP antagonists in the treatment of human immunodeficiency virus (HIV) in a mammal, alone or in combination with other therapeutic agents used in HIV therapy. In one aspect, provided herein is a method of treating human immunodeficiency virus (HIV) in an individual in need thereof comprising administering a therapeutically effective amount of at least one inhibitor of apoptosis proteins (IAP) antagonist.

Abstract: Provided herein are compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

Abstract: Provided herein are compounds that modulate the activity of inhibitor of apoptosis proteins (IAPB), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

Abstract: Provided herein is the use of compounds that modulate the activity of inhibitor of apoptosis proteins (1APs), alone or in combination with other therapeutic agents, in the treatment of human immunodeficiency virus (HIV). Described herein is the use of IAP antagonists in the treatment of human immunodeficiency virus (HIV) in a mammal, alone or in combination with other therapeutic agents used in HIV therapy. In one aspect, provided herein is a method of treating human immunodeficiency virus (HIV) in an individual in need thereof comprising administering a therapeutically effective amount of at least one inhibitor of apoptosis proteins (IAP) antagonist.

Abstract: Provided herein are compounds that modulate the activity of inhibitor of apoptosis proteins (IAPB), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

Abstract: Provided herein are compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

Abstract: Provided herein are compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

Abstract: A method and apparatus is described for dynamic relocation of a job executing on multiple nodes of a high performance computing (HPC) systems. The job is dynamically relocated when the messaging network is in a quiescent state. The messaging network is quiesced by signaling the job to suspend execution at a global collective operation of the job where the messaging of the job is known to be in a quiescent state. When all the nodes have reached the global collective operation and paused, the job is relocated and execution is resumed at the new location.

Abstract: A method and apparatus is described for dynamic relocation of a job executing on multiple nodes of a high performance computing (HPC) systems. The job is dynamically relocated when the messaging network is in a quiescent state. The messaging network is quiesced by signaling the job to suspend execution at a global collective operation of the job where the messaging of the job is known to be in a quiescent state. When all the nodes have reached the global collective operation and paused, the job is relocated and execution is resumed at the new location.